About
Butrint Aliu joined Pureos Bioventures in 2023 and previously led an antiviral drug development project at the University of Basel. He collaborated with Polyneuron Pharmaceuticals AG on novel therapies targeting rare neurological disorders during his PhD.
Sign up to see Dr. Butrint Aliu's full profile
Access investment thesis, focus areas, bio, and contact details for Dr. Butrint Aliu and 22,000+ other VC professionals.
Pureos Bioventures
Pfäffikon, CH